←Back to Expert Scholars
Translational Medicine / 转化医学Advanced Basal Cell Carcinoma
Mathew Hoffmann
MD
🏢Sun Pharmaceutical Industries🌐USA
Clinical Scientist
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mathew Hoffmann has contributed to clinical development of Hedgehog inhibitors for advanced basal cell carcinoma and supports regulatory and post approval studies. His work advances optimal use of sonidegib in clinical practice. He bridges industry and academic trials.
Share:
🧪Research Fields 研究领域
basal cell carcinoma
Hedgehog inhibitors
sonidegib
clinical development
dermato oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mathew Hoffmann 的研究动态
Follow Mathew Hoffmann's research updates
留下邮箱，当我们发布与 Mathew Hoffmann（Sun Pharmaceutical Industries）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment